TY - JOUR
T1 - Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond – Like syndrome
AU - Bellanné-Chantelot, Christine
AU - Schmaltz-Panneau, Barbara
AU - Marty, Caroline
AU - Fenneteau, Odile
AU - Callebaut, Isabelle
AU - Clauin, Séverine
AU - Docet, Aurélie
AU - Damaj, Gandhi Laurent
AU - Leblanc, Thierry
AU - Pellier, Isabelle
AU - Stoven, Cécile
AU - Souquere, Sylvie
AU - Antony-Debré, Iléana
AU - Beaupain, Blandine
AU - Aladjidi, Nathalie
AU - Barlogis, Vincent
AU - Bauduer, Frédéric
AU - Bensaid, Philippe
AU - Boespflug-Tanguy, Odile
AU - Berger, Claire
AU - Bertrand, Yves
AU - Carausu, Liana
AU - Fieschi, Claire
AU - Galambrun, Claire
AU - Schmidt, Aline
AU - Journel, Hubert
AU - Mazingue, Françoise
AU - Nelken, Brigitte
AU - Quah, Thuan Chong
AU - Oksenhendler, Eric
AU - Ouachée, Marie
AU - Pasquet, Marlène
AU - Saada, Véronique
AU - Suarez, Felipe
AU - Pierron, Gérard
AU - Vainchenker, William
AU - Plo, Isabelle
AU - Donadieu, Jean
N1 - Publisher Copyright:
© 2018 by The American Society of Hematology.
PY - 2018/9/20
Y1 - 2018/9/20
N2 - Congenital neutropenias (CNs) are rare heterogeneous genetic disorders, with about 25% of patients without known genetic defects. Using whole-exome sequencing, we identified a heterozygous mutation in the SRP54 gene, encoding the signal recognition particle (SRP) 54 GTPase protein, in 3 sporadic cases and 1 autosomal dominant family. We subsequently sequenced the SRP54 gene in 66 probands from the French CN registry. In total, we identified 23 mutated cases (16 sporadic, 7 familial) with 7 distinct germ line SRP54 mutations including a recurrent in-frame deletion (Thr117del) in 14 cases. In nearly all patients, neutropenia was chronic and profound with promyelocytic maturation arrest, occurring within the first months of life, and required long-term granulocyte colony-stimulating factor therapy with a poor response. Neutropenia was sometimes associated with a severe neurodevelopmental delay (n 5 5) and/or an exocrine pancreatic insufficiency requiring enzyme supplementation (n 5 3). The SRP54 protein is a key component of the ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER). We showed that SRP54 was specifically upregulated during the in vitro granulocytic differentiation, and that SRP54 mutations or knockdown led to a drastically reduced proliferation of granulocytic cells associated with an enhanced P53-dependent apoptosis. Bone marrow examination of SRP54-mutated patients revealed a major dysgranulopoiesis and features of cellular ER stress and autophagy that were confirmed using SRP54-mutated primary cells and SRP54 knockdown cells. In conclusion, we characterized a pathological pathway, which represents the second most common cause of CN with maturation arrest in the French CN registry.
AB - Congenital neutropenias (CNs) are rare heterogeneous genetic disorders, with about 25% of patients without known genetic defects. Using whole-exome sequencing, we identified a heterozygous mutation in the SRP54 gene, encoding the signal recognition particle (SRP) 54 GTPase protein, in 3 sporadic cases and 1 autosomal dominant family. We subsequently sequenced the SRP54 gene in 66 probands from the French CN registry. In total, we identified 23 mutated cases (16 sporadic, 7 familial) with 7 distinct germ line SRP54 mutations including a recurrent in-frame deletion (Thr117del) in 14 cases. In nearly all patients, neutropenia was chronic and profound with promyelocytic maturation arrest, occurring within the first months of life, and required long-term granulocyte colony-stimulating factor therapy with a poor response. Neutropenia was sometimes associated with a severe neurodevelopmental delay (n 5 5) and/or an exocrine pancreatic insufficiency requiring enzyme supplementation (n 5 3). The SRP54 protein is a key component of the ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER). We showed that SRP54 was specifically upregulated during the in vitro granulocytic differentiation, and that SRP54 mutations or knockdown led to a drastically reduced proliferation of granulocytic cells associated with an enhanced P53-dependent apoptosis. Bone marrow examination of SRP54-mutated patients revealed a major dysgranulopoiesis and features of cellular ER stress and autophagy that were confirmed using SRP54-mutated primary cells and SRP54 knockdown cells. In conclusion, we characterized a pathological pathway, which represents the second most common cause of CN with maturation arrest in the French CN registry.
UR - http://www.scopus.com/inward/record.url?scp=85054020211&partnerID=8YFLogxK
U2 - 10.1182/blood-2017-12-820308
DO - 10.1182/blood-2017-12-820308
M3 - Article
C2 - 29914977
AN - SCOPUS:85054020211
SN - 0006-4971
VL - 132
SP - 1318
EP - 1331
JO - Blood
JF - Blood
IS - 12
ER -